Background: The World Health Organization launched the Global Programme to Eliminate Lymphatic Filariasis in 2000, which aimed at eradicating the disease by 2030. This goal depends on community mass drug administration and essential care. Despite these efforts, many rural communities still face untreated lymphatic filariasis and lack access to treatment and self-management. Using a socioecological model, this study examined barriers to treatment and support for people living with lymphatic filariasis in Uganda's Buvuma and Napak districts.

Methods: We conducted 12 key informant interviews with health facility officials, district health officers, and village health team members. Additionally, 19 focus group discussions were held with community members, and nine in-depth interviews were conducted with people living with lymphatic filariasis. This study explored knowledge gaps among those living with lymphatic filariasis and health providers that affect morbidity management and disability prevention, as well as challenges in accessing treatment. Audio recordings were transcribed and managed via ATLAS ti software version 6. Thematic analysis was conducted via the socioecological model framework.

Results: This study identified multiple complex factors affecting healthcare providers and individuals living with lymphatic filariasis, spanning individual, interpersonal, organisational, community, and policy levels. The key themes included stigma and social isolation, healthcare disparities, and healthcare dynamics. Stigma and social isolation result in emotional distress, neglect, exclusion, and self-isolation, which are influenced by community beliefs. Health systems and policy barriers included poverty, inadequate personnel, and insufficient equipment. Structural factors such as geographical remoteness, environmental harshness, and lack of healthcare infrastructure were prominent obstacles to seeking care for lymphatic filariasis management.

Conclusion: This study provides insights into the multilevel factors influencing the understanding and availability of treatment for lymphatic filariasis in Uganda. Addressing sociocultural beliefs, social and interpersonal dynamics, and healthcare disparities is crucial for improving the outcomes and well-being of these rural communities. These findings can aid in managing lymphatic filariasis in Uganda and similar low-resource settings.

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0012747DOI Listing

Publication Analysis

Top Keywords

lymphatic filariasis
40
living lymphatic
16
lymphatic
10
filariasis
10
accessing treatment
8
treatment lymphatic
8
buvuma napak
8
rural communities
8
socioecological model
8
people living
8

Similar Publications

Background: The World Health Organization launched the Global Programme to Eliminate Lymphatic Filariasis in 2000, which aimed at eradicating the disease by 2030. This goal depends on community mass drug administration and essential care. Despite these efforts, many rural communities still face untreated lymphatic filariasis and lack access to treatment and self-management.

View Article and Find Full Text PDF

Background: People with disabilities due to neglected tropical diseases (NTDs), such as leprosy and lymphatic filariasis (LF), often encounter situations of stigma and discrimination that significantly impact their mental wellbeing. Mental wellbeing services are often not available at the peripheral level in NTD-endemic countries, and there is a need for such services. Basic psychological support for persons with NTDs (BPS-N) from peers is an important potential solution for addressing mental wellbeing problems.

View Article and Find Full Text PDF

The effects of variable spatial aggregation on lymphatic filariasis transmission.

Parasit Vectors

January 2025

National Centre for Epidemiology and Population Health, Australian National University, 62 Mills Road, Canberra, 2601, ACT, Australia.

Background: Elimination of lymphatic filariasis (LF) is a World Health Organization goal, with several countries at or near prevalence thresholds. Where LF cases remain after mass drug administration, they tend to be spatially clustered, with an overdispersed individual worm burden. Both individual and spatial heterogeneities can cause aggregation of infection; however, few studies have investigated the drivers of heterogeneity and implications for disease elimination.

View Article and Find Full Text PDF

is a parasite transmitted by mosquitoes and can cause a neglected tropical disease called Lymphatic filariasis. However, the genome of was not well studied, making novel drug development difficult. This study aims to identify microRNA, annotate protein function, and explore the pathogenic mechanism of by genome-wide analysis.

View Article and Find Full Text PDF

Introduction: This paper presents (a) the progress made towards achieving the 2023 Lymphatic Filariasis (LF) Mass Drug Administration (MDA) campaign goals, (b) the estimated financial savings resulting from integrating LF MDA into Polio immunization campaigns, and (c) the best practices, challenges, and recommendations.

Methods: In 2023, 21,336,057 people in 83 districts were affected by LF and required Preventive Chemotherapy (PC). The National NTD Control Programme (NTDCP) conducted three phases of LF MDA campaigns in those districts.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!